Skip to content

the efficiency and safety of the deodorAnt Pad against Odor and uLceration for LOcal advanced breast cancer

the efficiency and safety of the new deodorant pad for breast cancer with skin ulcerations or diffusion - breast cancer deodorant pad test

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036906
Enrollment
20
Registered
2019-06-01
Start date
2019-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

deodorant pad for breast cancer

Sponsors

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
Lead Sponsor
The Juntendo University Nerima Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: breast cancer patients with ulcerations or effusion

Exclusion criteria

Exclusion criteria: Patients in bad condition

Design outcomes

Primary

MeasureTime frame
A trial: the comparison of the deodorant effect between the new deodorant pad and the traditional pad for three days B trial: the safety of the continuous use of the deodorant pad for one month

Secondary

MeasureTime frame
deodorant effect the frequency to change the pad the work sheet result

Countries

Japan

Contacts

Public ContactToshiyuki Ishiba

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Breast Surgery

ishiba0313@gmail.com03-3823-2101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026